SonoVascular Completes First Close of Series A Preferred Stock Financing

CHAPEL HILL, N.C., Feb. 3, 2026 /PRNewswire/ -- SonoVascular, Inc., a clinical stage medical device company focused on transforming the treatment of venous thromboembolism (VTE) with its SonoThrombectomy™ System, has completed the first close of its $6 million Series A preferred stock...